Agency Agreements in the Biotechnology Industry
226 Contracts & Agreements
- AbbVie Inc. (2 contracts)
- ACHIEVE LIFE SCIENCES, INC. (1)
- Adhera Therapeutics, Inc. (1)
- ADiTx Therapeutics, Inc. (1)
- ADMA BIOLOGICS, INC. (1)
- ALBIREO PHARMA, INC. (2)
- Allarity Therapeutics, Inc. (3)
- Altimmune, Inc. (4)
- AMICUS THERAPEUTICS, INC. (1)
- AmpliPhi Biosciences Corp (1)
- Anixa Biosciences Inc (1)
- Aprea Therapeutics, Inc. (1)
- Aptevo Therapeutics Inc. (1)
- ARCA biopharma, Inc. (5)
- ASSEMBLY BIOSCIENCES, INC. (1)
- ATHERSYS, INC (5)
- ATOSSA GENETICS INC (3)
- Avid Bioservices, Inc. (1)
- AzurRx BioPharma, Inc. (4)
- Benitec Biopharma Inc. (2)
- BIO-PATH HOLDINGS INC (5)
- bioAffinity Technologies, Inc. (1)
- BioCardia, Inc. (2)
- BIOCEPT INC (6)
- BIOCRYST PHARMACEUTICALS INC (1)
- BioRestorative Therapies, Inc. (1)
- BRAINSTORM CELL THERAPEUTICS INC. (2)
- CAPRICOR THERAPEUTICS, INC. (1)
- Cellectar Biosciences, Inc. (3)
- Celsion CORP (3)
- Chardan Healthcare Acquisition Corp. (1)
- Cidara Therapeutics, Inc. (1)
- CLEVELAND BIOLABS INC (2)
- CohBar, Inc. (1)
- CONTRAFECT Corp (2)
- Corbus Pharmaceuticals Holdings, Inc. (1)
- CTD HOLDINGS INC (1)
- Cyclacel Pharmaceuticals, Inc. (3)
- DelMar Pharmaceuticals, Inc. (4)
- Diffusion Pharmaceuticals Inc. (2)
- Emerald Bioscience, Inc. (1)
- Enochian Biosciences Inc (4)
- Fortress Biotech, Inc. (2)
- GALECTIN THERAPEUTICS INC (1)
- Galera Therapeutics, Inc. (1)
- Gene Biotherapeutics, Inc. (2)
- Genprex, Inc. (4)
- GX Acquisition Corp. (3)
- HEAT BIOLOGICS, INC. (1)
- iBio, Inc. (2)
- InMed Pharmaceuticals Inc. (1)
- Inmune Bio, Inc. (1)
- INSMED Inc (1)
- International Stem Cell CORP (1)
- Isoray, Inc. (2)
- KBL MERGER CORP. IV (1)
- LEAP THERAPEUTICS, INC. (1)
- LEXICON PHARMACEUTICALS, INC. (1)
- LONGEVERON LLC (1)
- MARIZYME INC (3)
- Marker Therapeutics, Inc. (2)
- MATEON THERAPEUTICS INC (3)
- Matinas BioPharma Holdings, Inc. (2)
- Moleculin Biotech, Inc. (4)
- Momenta Pharmaceuticals, Inc. (1)
- NANOVIRICIDES, INC. (1)
- NantKwest, Inc. (3)
- NEUROTROPE BIOSCIENCE, INC. (1)
- Neurotrope, Inc. (1)
- NEWLINK GENETICS CORP (2)
- NORTHWEST BIOTHERAPEUTICS INC (1)
- NTN BUZZTIME INC (1)
- Ohr Pharmaceutical Inc (1)
- OncBioMune Pharmaceuticals, Inc (1)
- ONCOSEC MEDICAL Inc (2)
- ORAGENICS INC (1)
- ORGANOVO HOLDINGS, INC. (1)
- Orgenesis Inc. (1)
- Petra Acquisition Inc. (9)
- Phio Pharmaceuticals Corp. (1)
- PLURISTEM THERAPEUTICS INC (1)
- POLARITYTE, INC. (2)
- Propanc Biopharma, Inc. (1)
- Q BioMed Inc. (1)
- REGENERX BIOPHARMACEUTICALS INC (1)
- RenovoRx, Inc. (1)
- REXAHN PHARMACEUTICALS, INC. (2)
- Rezolute, Inc. (1)
- RITTER PHARMACEUTICALS INC (6)
- SANGAMO THERAPEUTICS, INC (1)
- Sarepta Therapeutics, Inc. (2)
- Scholar Rock Holding Corp (1)
- SELLAS Life Sciences Group, Inc. (3)
- Seres Therapeutics, Inc. (1)
- Shuttle Pharmaceuticals Holdings, Inc. (1)
- SOLENO THERAPEUTICS INC (1)
- SOLIGENIX, INC. (5)
- SOPHIRIS BIO INC. (1)
- SPHERIX INC (2)
- Sun BioPharma, Inc. (8)
- SYNLOGIC, INC. (1)
- Synthetic Biologics, Inc. (1)
- TENAX THERAPEUTICS, INC. (9)
- Tonix Pharmaceuticals Holding Corp. (4)
- Trovagene, Inc. (1)
- Unicycive Therapeutics, Inc. (1)
- VACCINEX, INC. (1)
- VistaGen Therapeutics, Inc. (1)
- VITAL THERAPIES INC (1)
- WINDTREE THERAPEUTICS INC (1)
- YIELD10 BIOSCIENCE, INC. (4)
- ZIOPHARM ONCOLOGY INC (2)
- Form of Placement Agency Agreement (Aptevo Therapeutics Inc., Filed With SEC on March 20, 2024)
- Placement Agency Agreement, dated as of March 11, 2024, by and between Aprea Therapeutics, Inc. and Maxim Group LLC (Aprea Therapeutics, Inc., Filed With SEC on March 12, 2024)
- Placement Agency Agreement, dated March 6, 2024, by and among the Company and Wallachbeth Capital LLC (bioAffinity Technologies, Inc., Filed With SEC on March 8, 2024)
- Form of Placement Agency Agreement (BIO-PATH HOLDINGS INC, Filed With SEC on March 8, 2024)
- Placement Agency Agreement, dated March 4, 2024, by and among Perspective Therapeutics, Inc. and Oppenheimer & Co. Inc (Isoray, Inc., Filed With SEC on March 6, 2024)
- Form of Placement Agency Agreement (AzurRx BioPharma, Inc., Filed With SEC on March 5, 2024)
- Offering Deposit Account Agency Agreement, dated February 7, 2024, between Shuttle Pharmaceuticals Holdings, Inc., Boustead Securities, LLC and Sutter Securities Inc (Shuttle Pharmaceuticals Holdings, Inc., Filed With SEC on February 13, 2024)
- Placement Agency Agreement, dated as of February 8, 2024, by and between Tenax Therapeutics, Inc. and Roth Capital Partners, LLC (TENAX THERAPEUTICS, INC., Filed With SEC on February 12, 2024)
- Placement Agency Agreement dated as of February 1, 2024 by and between Revelation Biosciences, Inc.and Roth Capital Partners, LLC (Petra Acquisition Inc., Filed With SEC on February 8, 2024)
- Form of Placement Agency Agreement by and between Tenax Therapeutics, Inc. and Roth Capital Partners, LLC, as exclusive placement agent thereunder (TENAX THERAPEUTICS, INC., Filed With SEC on February 1, 2024)
- Form of Placement Agency Agreement with Roth Capital Partners, LLC (Petra Acquisition Inc., Filed With SEC on January 29, 2024)
- Placement Agency Agreement dated as of January 28, 2024 by and between Panbela Therapeutics, Inc. and Roth Capital Partners, LLC (Sun BioPharma, Inc., Filed With SEC on January 29, 2024)
- Form of Placement Agency Agreement (BIO-PATH HOLDINGS INC, Filed With SEC on January 23, 2024)
- Form of Placement Agency Agreement (Celsion CORP, Filed With SEC on January 18, 2024)
- Form of Placement Agency Agreement with Roth Capital Partners, LLC (Sun BioPharma, Inc., Filed With SEC on January 4, 2024)
- Placement Agency Agreement, dated December 29, 2023, by and between the Company and Roth Capital Partners, LLC (Fortress Biotech, Inc., Filed With SEC on January 3, 2024)
- Placement Agency Agreement by and between the Company and Ladenburg Thalmann & Co. Inc., dated December 21, 2023 (Cyclacel Pharmaceuticals, Inc., Filed With SEC on December 26, 2023)
- Form of Placement Agency Agreement with Roth Capital Partners, LLC (Petra Acquisition Inc., Filed With SEC on December 22, 2023)
- Form of Placement Agency Agreement (Moleculin Biotech, Inc., Filed With SEC on December 21, 2023)
- Form of Placement Agency Agreement (AzurRx BioPharma, Inc., Filed With SEC on December 18, 2023)
- Placement Agency Agreement, dated December 5, 2023, by and between iBio, Inc. and A.G.P./Alliance Global Partners and Brookline Capital Markets, a division of Arcadia Securities,... (iBio, Inc., Filed With SEC on December 6, 2023)
- Form of Placement Agency Agreement (Allarity Therapeutics, Inc., Filed With SEC on December 5, 2023)
- Form of Placement Agency Agreement (iBio, Inc., Filed With SEC on November 30, 2023)
- Form of Placement Agency Agreement, dated November 10, 2023, by and between the Company and Roth Capital Partners, LLC (Fortress Biotech, Inc., Filed With SEC on November 14, 2023)
- Form of Placement Agency Agreement (DelMar Pharmaceuticals, Inc., Filed With SEC on October 24, 2023)
- Placement Agency Agreement, dated as of September 28, 2023, by and between Vaccinex, Inc. and A.G.P./Alliance Global Partners (VACCINEX, INC., Filed With SEC on October 4, 2023)
- Placement Agency Agreement, dated as of September 28, 2023, by and among Soleno Therapeutics, Inc. and the placement agents named therein (SOLENO THERAPEUTICS INC, Filed With SEC on September 29, 2023)
- Placement Agency Agreement, dated August 9, 2023, by and between 180 Life Sciences Corp. and A.G.P./Alliance Global Partners (KBL MERGER CORP. IV, Filed With SEC on August 15, 2023)
- Placement Agency Agreement, dated as of August 10, 2023, by and among the Company, Maxim Group LLC, and Lake Street Capital Markets, LLC (YIELD10 BIOSCIENCE, INC., Filed With SEC on August 11, 2023)
- Form of Placement Agency Agreement (ATHERSYS, INC, Filed With SEC on August 7, 2023)
- Placement Agency Agreement, dated as of August 3, 2023, by and between Bio-Path Holdings, Inc. and Roth Capital Partners, LLC (BIO-PATH HOLDINGS INC, Filed With SEC on August 7, 2023)
- Placement Agency Agreement (YIELD10 BIOSCIENCE, INC., Filed With SEC on August 2, 2023)
- Form of Placement Agency Agreement (BIO-PATH HOLDINGS INC, Filed With SEC on August 1, 2023)
- Placement Agency Agreement, dated as of July 27, 2023, by and between Celularity Inc. and the placement agent party thereto (GX Acquisition Corp., Filed With SEC on July 28, 2023)
- Form of Placement Agency Agreement (ATHERSYS, INC, Filed With SEC on July 26, 2023)
- Form of Placement Agency Agreement (AzurRx BioPharma, Inc., Filed With SEC on July 21, 2023)
- Placement Agency Agreement by and between the Company and Jefferies LLC, dated as of July 20, 2023 (NantKwest, Inc., Filed With SEC on July 21, 2023)
- Placement Agency Agreement, dated as of July 17, 2023, by and between the Company and the placement agent party thereto (BRAINSTORM CELL THERAPEUTICS INC., Filed With SEC on July 19, 2023)
- Form of Placement Agency Agreement, dated March 10, 2023 (MATEON THERAPEUTICS INC, Filed With SEC on July 13, 2023)
- PLACEMENT AGENCY AGREEMENT (BioRestorative Therapies, Inc., Filed With SEC on July 13, 2023)
